Also known as metastatic breast cancer (mBC), Stage IV means the disease has spread to other parts of the body, and approximately 1 in 3 people with breast cancer develop mBC.³ In Lynn’s case, her ...

The global intravenous (IV) fluid bags market is projected to grow at a compound annual growth rate (CAGR) of approximately 6% over the forecast period. Key factors driving this growth include the ...

The Danish drugmaker is collaborating with Vivtex, cofounded by billionaire Robert Langer, to quickly iterate oral versions ...

Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced the broadening of its NAD+ ...

If approved, Ojemda® (tovorafenib) is expected to be the first and only targeted medicine in European Union for children with relapsed or ...

For use outside the EU, the regulator backed a single-dose oral approach that treats all stages and could spare patients ...

The first and only approved achondroplasia therapy to provide continuous systemic exposure to CNP over the weekly dosing intervalCommercial ...

Allspring Premier Large Company Growth Fund lagged its benchmark in Q4 2025 but posted strong yearly gains. Read the full ...

Scientists at McGill University and the Rosalind and Morris Goodman Cancer Institute have developed a new way to deliver cancer immunotherapy that caused fewer side effects compared to standard ...

Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.

A new study published in the Journal of the American Medical Association showed that for juvenile dermatomyositis (JDM), a combination of intermittent intravenous methylprednisolone pulse ...

Science’s success at staving off death from heart disease or cancer has made another diagnosis more likely: Dementia.